- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
4119
TAI
Week ended 07 Aug 2026
Weekly Investor Report
SCI Pharmtech, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
51.60 TWD
9.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 7.8% above the Trend Line and sits at 54.6% of its 52-week range. The latest completed week returned 9.0%, after a 13.4% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
42
out of 100
Latest Close
51.60 TWD
7 Aug 2026
1W Return
9.0%
latest completed week
4W Return
13.4%
short-term follow-through
12W Return
29.9%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
9.0%
Latest completed week; four-week move 13.4%.
Indicator stack
0/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 7.8% above the Trend Line and sits at 54.6% of its 52-week range. The latest completed week returned 9.0%, after a 13.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1712-week average 0.08
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.17Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 13.4% over four weeks, 29.9% over 12 weeks, and -8.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.94Latest activity-pressure read.
Pressure change427.2%Four-week change in activity pressure.
Leadership-27.34Latest relative-leadership reading.
RS change34.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.0%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2611 weeks finished lower.
Best week+12.0%Week of 24 Jul.
Worst week-13.4%Week of 15 May.
Latest week+9.0%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains10
Flat weeks1
Modest losses9
Sharp losses2
Recent vol6.5%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split26/24Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank2 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - Specialty & Generic
4-week rank1 / 13
Group average-3.1%
Trend breadth23.1%
Trend23.1%active weekly trend signals
MD53.8%positive activity pressure
RS7.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape33/100
Trend, activity pressure, participation, and risk combine to a 33/100 tape read.
Indicator analysis17/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.17; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 51.60 TWD | 9.0% | 47.86 TWD | 72.35 TWD | 0.94 | -27.34 | 821.6K | Off |
| 31 Jul 2026 | 47.35 TWD | -8.8% | 47.73 TWD | 72.65 TWD | 0.71 | -32.61 | 1.6M | Off |
| 24 Jul 2026 | 51.90 TWD | 12.0% | 47.76 TWD | 72.95 TWD | 0.43 | -28.31 | 1.6M | Off |
| 17 Jul 2026 | 46.35 TWD | 1.9% | 47.64 TWD | 73.19 TWD | -0.01 | -35.58 | 790.7K | Off |
| 10 Jul 2026 | 45.50 TWD | 0.9% | 47.69 TWD | 73.51 TWD | -0.29 | -41.57 | 410.7K | Off |
| 3 Jul 2026 | 45.10 TWD | 3.1% | 47.75 TWD | 73.85 TWD | -0.40 | -45.00 | 950.8K | Off |
| 26 Jun 2026 | 43.76 TWD | 0.7% | 47.86 TWD | 74.18 TWD | -0.61 | -45.07 | 1.1M | Off |
| 19 Jun 2026 | 43.46 TWD | 6.3% | 47.95 TWD | 74.53 TWD | -0.75 | -48.70 | 789.8K | Off |
| 12 Jun 2026 | 40.90 TWD | 0.7% | 48.13 TWD | 74.88 TWD | -0.80 | -50.26 | 2.4M | Off |
| 5 Jun 2026 | 40.61 TWD | 1.2% | 48.61 TWD | 75.23 TWD | -0.86 | -52.63 | 1.1M | Off |
| 29 May 2026 | 40.12 TWD | -3.4% | 49.14 TWD | 75.57 TWD | -0.80 | -53.85 | 1.1M | Off |
| 22 May 2026 | 41.54 TWD | 4.6% | 49.75 TWD | 75.92 TWD | -0.77 | -50.52 | 1.0M | Off |
| 15 May 2026 | 39.72 TWD | -13.4% | 50.30 TWD | 76.32 TWD | -0.55 | -52.40 | 2.2M | Off |
| 8 May 2026 | 45.87 TWD | -2.4% | 50.93 TWD | 76.75 TWD | -0.35 | -46.79 | 919.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.